Gilteritinib
2215-CL-5101
Phase 2 small_molecule terminated
Quick answer
Gilteritinib for Non-Small-Cell Lung Cancer is a Phase 2 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Non-Small-Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated